Founded in 2021 by Joe Betts-LaCroix and initially funded with $180 million from OpenAI CEO Sam Altman, Retro aims to extend ...

For instance, In May 2022, Thermo Fisher and Charles River partnered with robotics company Multiply Labs to advance the automation of cell therapy production, with Thermo Fisher contributing Heracell ...

IT’S EXPANDING ITS FACILITY IN ROCKVILLE SPECIFICALLY TO WORK ON CELL THERAPY IN SPECIALLY DESIGNED LABS. IT WILL ALLOW ASTRAZENECA TO EXPAND THE AVAILABILITY OF THE PROCEDURE ALL OVER THE WORLD.

The findings, led by researchers in the Perelman School of Medicine at the University of Pennsylvania, were published in the New England Journal of Medicine. While CAR T cell therapy—a ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments ...

State officials and AstraZeneca marked the opening Monday of a cell therapy facility in Rockville ... Roughly 5,000 life sciences businesses and labs operate within Maryland.

Despite these advancements, more than 50% of patients with lymphoma do not have long-term remission with anti-CD19 CAR T-cell therapy. These patients have limited treatment options and poor prognoses.

While stem cell therapy holds great ... is critical. Beyond therapy, the technology may also aid drug testing by creating accurate neural models in labs. Future work could refine ultrasound ...

May 5 (Reuters) - Capricor Therapeutics (CAPR.O), opens new tab said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts before deciding on the ...